Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Brizo
Therapeutic Area : Urology
Study Phase : Undisclosed
Sponsor : Clalit
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Brizo is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Prostatic Hyperplasia.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
February 07, 2022
Lead Product(s) : Brizo
Therapeutic Area : Urology
Highest Development Status : Undisclosed
Sponsor : Clalit
Deal Size : Inapplicable
Deal Type : Inapplicable